Skip to main content
. 2021 Dec 15;13(12):13485–13497.

Table 1.

Comparison of demographics, blood analysis, CT, and FibroScan data prior to treatment

Variables Group 1 Group 2 Group 3 Group 4 F/χ2 value P value
Cases 40 50 44 30
Age (yr) 43.23±10.32 45.78±9.79 44.64±10.13 44.97±10.03 0.487 0.692
Gender (M/F) 24/16 31/19 26/18 18/12 0.090 0.993
Weight (kg) 61.21±7.87 66.89±7.37 77.67±9.00 86.65±9.32 66.512 <0.001
Height (m) 1.71±0.08 1.70±0.07 1.70±0.07 1.69±0.07 0.309 0.819
BMI (kg/m2) 20.90±1.43 22.99±1.60 26.98±2.05 30.09±1.70 206.955 <0.001
Cr (µmmol/L) 62.29±10.15 65.24±10.65 65.32±9.48 64.71±10.02 0.822 0.483
ALT (U/L) 23.29±8.90 51.95±12.56 80.78±13.48 107.05±13.57 314.269 <0.001
AST (U/L) 19.19±8.62 37.61±10.17 64.95±11.03 83.45±11.89 273.965 <0.001
GGT (U/L) 23.19±9.96 44.38±11.39 82.26±13.70 100.74±14.47 300.529 <0.001
TB (µmol/L) 10.84±3.77 11.69±3.72 12.43±3.99 15.55±4.53 8.936 <0.001
ALB (g/L) 47.77±4.00 48.08±4.03 46.87±3.26 47.40±3.42 0.894 0.445
TG (mmol/L) 1.03±0.35 1.90±0.40 2.61±0.50 3.48±0.53 195.923 <0.001
TC (mmol/L) 4.11±0.81 5.17±1.06 6.29±0.94 7.23±1.15 67.504 <0.001
HDL (mmol/L) 1.35±0.35 1.21±0.24 1.08±0.25 0.92±0.27 15.908 <0.001
LDL (mmol/L) 1.77±0.59 2.56±0.80 3.51±0.95 4.40±0.90 69.123 <0.001
FBG (mmol/L) 5.06±0.66 5.38±0.78 5.71±0.84 6.18±0.76 13.799 <0.001
FINS (mU/L) 7.30±1.81 11.45±2.50 18.31±2.23 22.87±2.44 343.172 <0.001
HOMA-IR 1.63±0.43 2.74±0.71 4.62±0.72 6.25±0.74 342.558 <0.001
liver/spleen CT ratio 1.12±0.06 0.84±0.08 0.60±0.05 0.30±0.08 932.026 <0.001
LSM (Kpa) 5.88±0.79 7.13±0.87 9.06±1.26 13.61±1.49 320.957 <0.001

Notes: Group 1 is healthy controls, Group 2 is mild fatty liver, Group 3 is moderate fatty liver, and Group 4 is severe fatty liver. Abbreviations: BMI: body mass index; Cr: creatinine; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: glutamyl transpeptidase; TB: total bilirubin; ALB: albumin; TG: triglyceride; TC: total cholesterol; HDL: high density lipoprotein cholesterol; LDL: low density lipoprotein cholesterol; FBG: fasting plasma glucose; FINS: fasting serum insulin; HOMA-IR: homeostasis model assessment of insulin resistance; LSM: liver stiffness measurement.